Displaying 31 - 40 of 194 results.
Daiane Bulgarelli, currently PhD student in the Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, São Paulo, Brasil, recently received the first prize award from the for her oral presentation at the 27th annual congress o ...
Oncofertility awareness increased this week when the Washington Post published an article on the critical subject. The piece, Oncofertility offers new options for young women with cancer who want to have kids, introduces the concept of oncofertility for c ...
Laxmi Kondapalli, MD, an Assistant Professor, Reproductive Endocrinology and Infertility at the University of Colorado, was recently interviewed on How On Earth, a half-hour National Public Radio audio magazine featuring short stories about the recent new ...
Congratulations to the Women Survivors Alliance on their first ever National Women's Survivors Convention- September 22-24, 2013.There are more than 7 million women cancer survivors in the United States who traveled the journey from healthy lives thr ...
Members of the NIH organized and co-chaired a symposium on Cancer and Pregnancy: Considerations Regarding the Use of Chemotherapy in Arizona this past June at the 53rd annual meeting of the  Teratology Society. ONcofertility Consortium member, Laxmi Konda ...
To help doctors give their patients the best possible care, the American Society of Clinical Oncology (ASCO) asks its medical experts to develop recommendations for specific areas of cancer care. In 2006, ASCO developed recommendations for fertility prese ...
Through oncofertility specialists, patients are now being counseled about options available to help maintain fertility prior to cancer treatment. Today, oncologists at the University of Colorado Cancer Center are referring patients of childbearing age to ...
In 2011, Oncofertility Consortium member, Laxmi Kondapalli, MD, MSCE, started Colorado's first fertility preservation program for cancer patients at CU School of Medicine. Recently, Dr. Kondapalli was featured in CU's philanthropy magazine, Crea ...
The Oncofertility Consortium is proud to announce that we have reached over 1,000 followers on Twitter! If you have not already, please follow our posts on the popular social media site, www.twitter.com/oncofertility. Not only do we post about cancer and ...
A new gentler chemotherapy drug in the form of nanoparticles has been designed by Northwestern Medicine® scientists to be less toxic to a young woman’s fertility but tough on cancer. This is the first cancer drug tested while in development for its effect ...

Pages

Most Recent Story

Joint Statement from the Alliance for Fertility Preservation and the Oncofertility Consortium on Fertility Preservation for Patients Receiving Gonadotoxic Therapies During the COVID-19 Pandemic During this uncertain and unprecedented time, the oncofertility community is working together to provide up-to-date fertility preservation information for patients and providers. We are aware of the recommendations from ASRM’s COVID-19 Task Force which suggests new IVF cycles not be initiated at this time. While this pause in services does not apply to urgent fertility preservation for patients...